FDA Approves First Immunotherapy for Breast Cancer
The US Food and Drug Administration approved first immunotherapy drug for Triple-Negative Breast Cancer Until recently, women with inoperable triple-negative breast cancer had one treatment option: chemotherapy. In March, FDA granted accelerated app...[Read more]